Journal

Patient medians for NT-proBNP from six Swedish counties 2011–2021​Morgan Lundgren Peter Ridefelt Maria K. Eriksson Thomas Cars Anders Larsson a Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Swedenb Department of Medical Sciences, Renal Medicine, Uppsala University, Uppsala, Swedenc Uppsala Clinical Research Centre, Uppsala, Swedend Sence Research AB, Uppsala, Swedenon July 4, 2025 at 12:40 pm

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 368-378.

Preanalytical factors of enhanced liver fibrosis (ELF™) laboratory testing: the score is affected by hemolysis​Anni Kelkka Christel Pussinen Lotta Joutsi-Korhonen Kari Pulkki Marja-Kaisa Koivula Anna Lempiäinen Department of Clinical Chemistry, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finlandon August 21, 2025 at 11:29 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 379-386.

Serum metabolic profiling in patients with hypothyroidism in pregnancy​Lei Zhang Mingjian Lian Yufan Wang Jiandong Zhang a Department of Clinical Laboratory, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, The Third Central Hospital of Tianjin, Tianjin Institute of Hepatobiliary Disease, Tianjin, Chinab Department of Clinical Laboratory, Xiamen Key Laboratory of Genetic Testing, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Chinaon August 13, 2025 at 5:50 am

by

Volume 85, Issue 5, SEPTEMBER 2025, Page 387-394.

Method comparison of plasma and CSF GFAP immunoassays across multiple platformsBurak Arslanon September 1, 2025 at 10:00 am

by

Clin Chem Lab Med. 2025 Sep 2. doi: 10.1515/cclm-2025-0667. Online ahead of print. ABSTRACT OBJECTIVES: Glial fibrillary acidic protein (GFAP) is a biomarker of astrocytic activation associated with neurodegenerative diseases, neuroinflammatory disorders, and traumatic brain injury. However, the lack of standardized methods for quantifying GFAP across different immunoassay platforms poses challenges for its clinical implementation. … Read more

Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic reviewSacha Pelletieron August 30, 2025 at 10:00 am

by

Clin Chem Lab Med. 2025 Sep 1. doi: 10.1515/cclm-2025-0678. Online ahead of print. ABSTRACT INTRODUCTION: The increasing use of therapeutic monoclonal antibodies (t-mAbs) has improved cancer and autoimmune disorder treatment. These therapeutics can interfere with serum protein electrophoresis (SPEP) and immunofixation (IF), potentially leading to the appearance of monoclonal bands that may be misinterpreted as … Read more

Serum sortilin as a potential diagnostic and therapeutic target for cardiovascular calcification in uremic patients: A single-center prospective and observational study​on August 30, 2025 at 9:50 am

by

Publication date: 1 January 2026 Source: Clinica Chimica Acta, Volume 578 Author(s): Yuxia Zhang, Jingjing Chen, Yan Di, Yongqi Li, Jing Lu, Yinan Zhao, Yujia Wang, Zhiqing Chen, Sheng Tang, Bicheng Liu, Min Gao, Rining Tang  

Determination of hair cortisol by liquid chromatography coupled to mass spectrometry (LC-MS/MS) as biomarker of chronic stress and application to academic students​on August 30, 2025 at 9:50 am

by

Publication date: 1 January 2026 Source: Clinica Chimica Acta, Volume 578 Author(s): Elena Giovannini, Francesca Rossi, Jacopo Lenzi, Eleonora Berretti, Simone Santelli, Assia Benkhalqui, Filippo Pirani, Luca Morini, Jennifer P. Pascali  

Error: Connection timed out (110)